Triple test score
Diagnostic tool for examining breasts
≈ 2 min read
Names in other languages
- EnglishTriple test score
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
The triple test score is a diagnostic tool for examining potentially cancerous breasts. Diagnostic accuracy of the triple test score is nearly 100%. Scoring includes using the procedures of physical examination, mammography and needle biopsy.
If the results of a triple test score are greater than five, an excisional biopsy is indicated. The term triple test scoring (TSS) was first noted in 1975 as a means of rapidly diagnosing and examining breast malignancies. TSS developed as a useful and accurate clinical tool for breast masses because it was cheaper and it cut down on the diagnosis time.
Scoring
To obtain the triple test score, a number from 1 through 3 is assigned to each one of the procedures. A score of 1 is assigned to a benign test result, 2 applies to a suspicious test result, and 3 applies to a malignant result. The sum of the scores of all three procedures is the triple test score.
If the total summed score from the three tests is 3 to 4 then the diagnosis is most likely benign. A total summed score of 5 is considered suspicious. A score of 6 or greater is possibly malignant.
There have been different inclusions for the components of the triple test score in the past, such as using the procedures of physical examination, mammography, and cytology. Other versions of the triple test score have included mammography, ultrasound, and magnetic resonance imaging (MRI).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1334954390 under CC BY-SA 4.0; modifications have been made.